Birchview Capital, LP Scholar Rock Holding Corp Transaction History
Birchview Capital, LP
- $124 Million
- Q3 2025
A detailed history of Birchview Capital, LP transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Birchview Capital, LP holds 26,000 shares of SRRK stock, worth $983,320. This represents 0.78% of its overall portfolio holdings.
Number of Shares
26,000
Previous 16,000
62.5%
Holding current value
$983,320
Previous $566,000
71.55%
% of portfolio
0.78%
Previous 0.6%
Shares
4 transactions
Others Institutions Holding SRRK
# of Institutions
276Shares Held
101MCall Options Held
2.02MPut Options Held
2.23M-
Siren, L.L.C. New York, NY9.25MShares$350 Million13.48% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.88MShares$260 Million0.03% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$214 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA5.61MShares$212 Million79.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.91MShares$186 Million0.0% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $1.95B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...